Morphinsulfat Gry (Morphine Sulfate)

Morphine sulfate is an opioid analgesic used to manage pain across several clinical settings.

• Severe acute pain: provides rapid relief of intense pain episodes.
• Post‑operative pain: controls pain following surgical procedures.
• Cancer pain: alleviates persistent pain associated with malignant disease.
• Chronic pain requiring opioid therapy: offers long‑term analgesia for patients with refractory chronic pain.

• Morphine sulfate acts as a full agonist at µ‑opioid receptors in the central nervous system. Binding to these G‑protein coupled receptors inhibits adenylate cyclase activity, reduces calcium influx, and increases potassium efflux, leading to decreased neuronal excitability and diminished transmission of nociceptive signals, resulting in analgesia, sedation, and respiratory depression.

Morphine sulfate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: feeling of queasiness often accompanied by vomiting.
• Constipation: reduced bowel motility leading to hard stools.
• Drowsiness: increased sleepiness or reduced alertness.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Itching: pruritus, especially around the face and neck.
• Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Anaphylactic reaction: sudden, severe allergic response with rash, swelling, and airway compromise.
• Adrenal insufficiency: impaired cortisol production leading to fatigue and weakness.
• Seizures: uncontrolled electrical activity in the brain.
• Dependence and withdrawal: physical reliance with symptoms upon abrupt cessation.

Morphine sulfate requires careful monitoring due to its potent opioid effects.

• Assess pain level: evaluate severity and type before initiating therapy.
• Monitor respiratory function: check breathing rate and oxygen saturation regularly.
• Evaluate opioid tolerance: adjust dose based on prior opioid exposure.
• Avoid use in severe respiratory depression: contraindicated in patients with compromised breathing.
• Use caution in renal or hepatic impairment: dose may need reduction.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Morphine sulfate can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines): may cause profound sedation and respiratory depression.
• MAO inhibitors: increase risk of hypertensive crisis and serotonin syndrome.
• Other opioids: additive respiratory depression and sedation.
• Alcohol: enhances central nervous system depression.
• Respiratory depressants (e.g., barbiturates): potentiate respiratory suppression.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., erythromycin): may raise morphine plasma levels.
• CYP3A4 inducers (e.g., rifampin): may reduce analgesic effect.
• Diuretics: can exacerbate hypotension.
• Antihistamines: increase sedation.
• Certain antidepressants (e.g., SSRIs): may heighten serotonin-related effects.